BB Biotech AG : Volatility at the beginning of the year but fundamentals remain solid
>Start of the year in the red for the sector - Like the last few months of 2021, 2022 has got off to a complicated start for the biotech sector. This was due to the impact of 1/ a "growth to value" sector rotation triggered by expectations of rising interest rates under inflationary pressure, 2/ fears of macroeconomic repercussions triggered by the Ukraine/Russia geopolitical situation and 3/ concerns of an upsurge in Covid cases (new lockdowns in China) and the emerg...Co.'s principal activity is to invest in biotechnology companies globally. The investments are held through its wholly-owned subsidiaries: Biotech Focus N.V., Biotech Invest N.V., Biotech Target N.V., and Biotech Growth N.V., all of which are located in Curacao. Co. acquires holdings in companies in the biotechnology growth market. The focus of the holdings is on quoted companies that are concentrating on the development and marketing of innovative medicines. For the selection of holdings, Co. relies on fundamental analysis by physicians and molecular biologists.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.